Valuation: Ginwa Enterprise (Group) Inc.

Market Cap 1.69B 251M 215M 201M 184M 346M 24.03B 353M 2.38B 928M 12.05B 943M 923M 39.88B P/E 2024
37.4x
P/E 2025 171x
Enterprise Value 1.34B 199M 170M 159M 146M 273M 19B 279M 1.88B 734M 9.52B 746M 729M 31.52B EV / Sales 2024
4.15x
EV / Sales 2025 4.24x
Free-Float
66.46%
Yield 2024
0.38%
Yield 2025 0.4%
1 day+2.57%
1 week-3.62%
Current month-0.83%
1 month+4.13%
3 months-18.12%
6 months-44.24%
Current year-36.47%
1 week 4.61
Extreme 4.61
4.88
1 month 4.45
Extreme 4.45
5.01
Current year 4.26
Extreme 4.26
9.3
1 year 4.26
Extreme 4.26
9.35
3 years 4.26
Extreme 4.26
9.35
5 years 4.26
Extreme 4.26
10.97
10 years 3.7
Extreme 3.7
14.93
Manager TitleAgeSince
Chief Executive Officer 59 2020-06-28
Director of Finance/CFO 44 2025-04-09
Corporate Officer/Principal 30 2022-02-15
Director TitleAgeSince
Director/Board Member 63 2011-04-20
Chairman 55 2020-06-28
Chairman 59 2022-02-21
Change 5-day change 1-year change 3-year change Capi.($)
+2.57%-3.62%-40.35%-35.44% 245M
-2.81%+2.93%+76.40%+127.73% 1,141B
-2.21%+2.02%+49.50%+55.01% 659B
-1.56%+4.39%+25.19%+74.39% 470B
+1.20%+2.62%+41.69%+45.78% 366B
-0.61%+2.10%+23.43%+41.34% 302B
+0.32%+3.25%+0.94%+13.42% 254B
-1.95%+3.80%+46.31%+65.66% 239B
-1.10%-0.70%-14.31%-52.66% 207B
-2.82%+3.84%+20.81%+89.04% 183B
Average -0.90%+2.42%+22.96%+42.42% 382.12B
Weighted average by Cap. -1.64%+3.12%+43.48%+70.85%

Financials

2024 2025
Net sales 585M 87.04M 74.53M 69.54M 63.81M 120M 8.33B 122M 825M 322M 4.17B 327M 320M 13.82B 544M 80.89M 69.25M 64.62M 59.29M 111M 7.74B 114M 767M 299M 3.88B 304M 297M 12.84B
Net income 74.61M 11.09M 9.5M 8.86M 8.13M 15.28M 1.06B 15.58M 105M 40.98M 532M 41.65M 40.75M 1.76B 15.58M 2.32M 1.98M 1.85M 1.7M 3.19M 222M 3.25M 21.95M 8.56M 111M 8.7M 8.51M 368M
Net Debt -327M -48.54M -41.56M -38.78M -35.58M -66.86M -4.64B -68.18M -460M -179M -2.33B -182M -178M -7.71B -354M -52.63M -45.06M -42.04M -38.58M -72.49M -5.04B -73.91M -499M -194M -2.52B -198M -193M -8.35B
Logo Ginwa Enterprise (Group) Inc.
Ginwa Enterprise Group Inc is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company operates its businesses through three segments. The Pharmaceutical Industry segment is mainly engaged in the production of pharmaceuticals. The Company's products are divided into four series, including orthopedics, immunology, children's and general medicines, mainly covering chemicals, Chinese patent medicines, active pharmaceutical ingredient and health care products. The Hotel Industry segment is mainly engaged in the operation of hotels. The Pharmaceutical Commercial segment is mainly engaged in the sales of pharmaceuticals. The Company mainly operates its businesses in the domestic market.
Employees
613
Date Price Change Volume
26-08-20 CN¥4.790 +2.57% 2,238,900
26-08-19 CN¥4.670 -2.51% 2,959,501
26-08-18 CN¥4.790 -1.64% 1,728,400
26-08-17 CN¥4.870 0.00% 2,039,700
26-08-14 CN¥4.870 -2.01% 2,156,700
  1. Stock Market
  2. Stocks
  3. 600080 Stock